» Articles » PMID: 32943463

ICD-10-AM Codes for Cirrhosis and Related Complications: Key Performance Considerations for Population and Healthcare Studies

Overview
Specialty Gastroenterology
Date 2020 Sep 18
PMID 32943463
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The utility of International Classification of Diseases (ICD) codes relies on the accuracy of clinical reporting and administrative coding, which may be influenced by country-specific codes and coding rules. This study explores the accuracy and limitations of the Australian Modification of the 10th revision of ICD (ICD-10-AM) to detect the presence of cirrhosis and a subset of key complications for the purpose of future large-scale epidemiological research and healthcare studies.

Design/method: ICD-10-AM codes in a random sample of 540 admitted patient encounters at a major Australian tertiary hospital were compared with data abstracted from patients' medical records by four blinded clinicians. Accuracy of individual codes and grouped combinations was determined by calculating sensitivity, positive predictive value (PPV), negative predictive value and Cohen's kappa coefficient (κ).

Results: The PPVs for 'grouped cirrhosis' codes (0.96), hepatocellular carcinoma (0.97) ascites (0.97) and 'grouped varices' (0.95) were good (κ all >0.60). However, codes under-detected the prevalence of cirrhosis, ascites and varices (sensitivity 81.4%, 61.9% and 61.3%, respectively). Overall accuracy was lower for spontaneous bacterial peritonitis ('grouped' PPV 0.75; κ 0.73) and the poorest for encephalopathy ('grouped' PPV 0.55; κ 0.21). To optimise detection of cirrhosis-related encounters, an ICD-10-AM code algorithm was constructed and validated in an independent cohort of 116 patients with known cirrhosis.

Conclusion: Multiple ICD-10-AM codes should be considered when using administrative databases to study the burden of cirrhosis and its complications in Australia, to avoid underestimation of the prevalence, morbidity, mortality and related resource utilisation from this burgeoning chronic disease.

Citing Articles

Trans-ancestral rare variant association study with machine learning-based phenotyping for metabolic dysfunction-associated steatotic liver disease.

Chen R, Petrazzini B, Duffy A, Rocheleau G, Jordan D, Bansal M Genome Biol. 2025; 26(1):50.

PMID: 40065360 PMC: 11892324. DOI: 10.1186/s13059-025-03518-5.


Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort.

Yoo H, Kim J, Yoo J, Lee H, Kim S, Kim Y JHEP Rep. 2025; 7(2):101268.

PMID: 39867683 PMC: 11762169. DOI: 10.1016/j.jhepr.2024.101268.


July effect in hospitalized cirrhosis patients: A US nationwide study using difference-in-differences analysis.

Celdir M, Wehby G, Prakash S, Tanaka T PLoS One. 2025; 20(1):e0316445.

PMID: 39804918 PMC: 11729967. DOI: 10.1371/journal.pone.0316445.


Screening for Alcohol Use Disorder Among Hospitalised Patients: Learning from a Retrospective Cohort Study in Secondary Care.

Subhani M, Nath D, Talat U, Imtiaz A, Khanna A, Ali A J Clin Med. 2025; 13(24.

PMID: 39768540 PMC: 11678479. DOI: 10.3390/jcm13247617.


Readmission Rate, Predictors, Outcomes, and Burden of Readmission of Hepatorenal Syndrome in the United States: A Nationwide Analysis.

Sohail A, Chaudhary A, Bhinder M, Zahid K, Brown K JGH Open. 2024; 8(11):e70062.

PMID: 39600414 PMC: 11588588. DOI: 10.1002/jgh3.70062.


References
1.
Niu B, Kim B, Limketkai B, Sun J, Li Z, Woreta T . Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA. Dig Dis Sci. 2018; 63(5):1327-1333. PMC: 5897146. DOI: 10.1007/s10620-018-4990-y. View

2.
Powell E, Skoien R, Rahman T, Clark P, OBeirne J, Hartel G . Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians. EClinicalMedicine. 2019; 11:44-53. PMC: 6610783. DOI: 10.1016/j.eclinm.2019.05.007. View

3.
Hayward K, Patel P, Valery P, Horsfall L, Li C, Wright P . Medication-Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention. Hepatol Commun. 2019; 3(5):620-631. PMC: 6492469. DOI: 10.1002/hep4.1334. View

4.
Ramachandran J, Hossain M, Hrycek C, Tse E, Muller K, Woodman R . Coordinated care for patients with cirrhosis: fewer liver-related emergency admissions and improved survival. Med J Aust. 2018; 209(7):301-305. DOI: 10.5694/mja17.01164. View

5.
OMalley K, Cook K, Price M, Wildes K, Hurdle J, Ashton C . Measuring diagnoses: ICD code accuracy. Health Serv Res. 2005; 40(5 Pt 2):1620-39. PMC: 1361216. DOI: 10.1111/j.1475-6773.2005.00444.x. View